SCHEMBL7931264

SCHEMBL7931264

COC(=O)C=C(N)c1ccc(Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 1/20 0.45
HPGD P15428 1/20 0.44
LMNA P02545 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
NPC1 O15118 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
CES2 O00748 2/20 0.42
CES1 P23141 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7931260 1.00 RAB9A (0.45) RAB9AMAPK1HSD17B10HPGDLMNA
SCHEMBL6657569 0.84 TDP1 (0.52) RAB9AMAPK1HSD17B10HPGDLMNA
SCHEMBL6657574 0.84 TDP1 (0.52) RAB9AMAPK1HSD17B10HPGDLMNA
SCHEMBL6661088 0.82 RAB9A (0.66) RAB9AMAPK1HSD17B10ALDH1A1CYP1A2
SCHEMBL6661082 0.82 RAB9A (0.66) RAB9AMAPK1HSD17B10ALDH1A1CYP1A2
SCHEMBL14691237 0.82 SMN1; SMN2 (0.59) RAB9AMAPK1HSD17B10HPGDALDH1A1
SCHEMBL1928738 0.82 SMN1; SMN2 (0.59) RAB9AMAPK1HSD17B10HPGDALDH1A1
SCHEMBL7933746 0.82 RAB9A (0.66) RAB9AMAPK1HSD17B10ALDH1A1CYP1A2
SCHEMBL2649166 0.82 SMN1; SMN2 (0.59) RAB9AMAPK1HSD17B10HPGDALDH1A1
SCHEMBL3521887 0.81 PDE4A (0.49) RAB9AHPGDLMNAL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010031865-A1 Substituted 3-phenyluracils KLINTZ RALF (DE) 2001-10-18 US disclosed
US-6239074-B1 HERBICIDES, INSECTICIDES BASF AKTIENGESELLSCHAFT (DE) 2001-05-29 US disclosed
US-4540791-A FROM A NITRICE AND A HALO ESTER CIBA-GEIGY CORPORATION (US) 1985-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031865-A1 Substituted 3-phenyluracils CCR1, CCR6, CCR3 RAB9A 3028/4885MAPK1 3667/4885HSD17B10 1401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.